Are You Using the Right Recruitment Strategies for Your Diabetes Clinical Trial?

Diabetes patient recruitment

Are You Using the Right Recruitment Strategies for Your Diabetes Clinical Trial?

Twenty nine million Americans are living with diabetes; that’s 1 out of every 11 people1. The Centers for Disease Control and Prevention predicts a staggering growth in the disease’s prevalence: by 2050, 1 in 3 Americans will have diabetes.

To tackle the growing challenges of this disease, many of our manufacturer partners are working hard to develop new and innovative options that treat the disease and improve the quality of life for patients. However, many sponsors find that diabetes studies are difficult to enroll due to competing trials, complex protocols, low study participation among high-risk populations, as well as difficulty identifying, targeting, and initiating high-performance sites.

UBC’s Patient and Physician Services (PPS) team is well-versed in the diabetes therapeutic area. We have recruited more than 5,000 people with diabetes for more than 7 diabetes trials in the last few years.

UBC understands:

The diabetes market is competitive: PhRMA’s Diabetes Medicines in Development report found that there were nearly 200 active diabetes clinical trials in the United States in 2014, including 140 that had not yet started. The nature of the trials creates a competitive market for recruiting patients and prescribers for study participation.

As an Express Scripts company, UBC has access to unmatched real-world data, allowing us to identify the right sites and patients and effectively accelerate study enrollment. UBC can connect sponsors to more than 2.5 million diabetes patients through the Express Scripts proprietary PBM database. There are many advantages to utilizing this database for diabetes patient recruitment, such as data quality and enhanced targeting based on inclusion criteria.

UBC has successful relationships with several diabetes advocacy groups and online communities that have partnered with us in promoting clinical trial participation.

Our PPS team can also provide site feasibility and selection services, including the use of Express Scripts’ patient data to locate prescribers treating patients for sponsors’ specific study protocols. UBC has conducted outreach to more than 2,000 investigators.

Diabetes patients are diverse: According to the American Diabetes Association, more than 200,000 people under the age of 20 have diabetes; 12.3 % of people 20 years or older have diabetes and 11.2 million people 65 years or older have diabetes.

Our PPS team knows that in order to have an effective clinical trial recruitment strategy, you must utilize different marketing tactics to successfully accommodate the different demographics among diabetic patients.

One of these recruitment marketing tactics is the utilization of social media sites, such as Facebook. Facebook offers many advantages in patient recruitment and retention, like accommodations for the many different generational groups that diabetic patients fall into. A recent study conducted by the PewResearchCenter found that among all American internet users, 71% are on Facebook and more than half of all online adults 65 and older use Facebook. Recently, UBC provided recruitment services on a Phase 3 diabetes clinical trial. Within three months of launching a Facebook page for the study, enrollment increased from 2 to 48 patients.

By combining our diabetes knowledge and experience with Express Scripts’ data, UBC is uniquely positioned to provide your diabetes clinical trial with innovative patient and physician recruitment and retention solutions. Contact us today to put our unique recruitment and retention strategies to work for your diabetes trial.

1 American Diabetes Association